Wednesday, June 20, 2018
 
 
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
TM3 Therapeutics Debuts with Publication of In Vivo Proof of Concept Data for Lead Compound in Treating Pantothenate Kinase-Associated Neurodegeneration

(September 13, 2017)
[ServletException in:/common/layout/us_view_template.jsp] null'